|
Volumn , Issue 2, 2003, Pages
|
Treatment for Lambert-Eaton myasthenic syndrome.
a
a
Sinfin
*
(United Kingdom)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3,4 DIAMINOPYRIDINE;
3,4-DIAMINOPYRIDINE;
4 AMINOPYRIDINE;
DRUG DERIVATIVE;
IMMUNOGLOBULIN;
POTASSIUM CHANNEL BLOCKING AGENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
EATON LAMBERT SYNDROME;
HUMAN;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
4-AMINOPYRIDINE;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
LAMBERT-EATON MYASTHENIC SYNDROME;
POTASSIUM CHANNEL BLOCKERS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 18744429376
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (73)
|
References (37)
|